New cellular therapy offers hope for multiple myeloma patients

UChicago Medicine is the first program in Chicago to offer Abecma, a cell-based gene therapy for patients with treatment-resistant multiple myeloma.

A more comfortable mammogram? Yes, plus other new state-of-the-art breast cancer screening tools
Low-dose, four-drug combo blocks cancer's spread in mice